TC
APEN

Trium Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Trium Capital’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-992,046
Closed -$9.84M – 105
2023
Q1 		$9.84M Buy
992,046
+959,558
+2,954% +$9.5M 3.41% 5
2022
Q4 		$324K Buy
+32,488
New +$242K 0.12% 66

Trium Capital's APEN Position: Q2 2023 in Review

Trium Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 992,046 shares — an estimated $9.84M sold.

Trium Capital first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $9.84M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Trium Capital reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Trium Capital sold 992,046 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $9.84M.
  • Trium Capital first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Trium Capital's Apollo Endosurgery, Inc. position peaked at $9.84M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Trium Capital's 13F filing for Q2 2023, filed 11 Aug 2023.